The new antibiotic drug Zabicefta is entering the prescription range of general hospitals.

According to related industries, Pfizer Pharmaceuticals Korea's Zavicefta is being used in tertiary general hospitals such as SMC, Seoul St. Mary's Hospital, Asan Medical Center in Seoul, and Sinchon Severance Hospital, as well as Gangnam Severance Hospital, Korea University Guro Hospital, Korea University Ansan Hospital, National Cancer Center, and Ewha Womans University Mokdong Hospital. It has passed the Drug Committee (DC) of 39 medical institutions across the country.

Zavicefta was developed to respond to the urgent need for a new antibiotic for serious infections where drug resistance is a se